Loading interface...

Lacarnit 330 mg Tablet

Manufactured byLa Renon Healthcare
Description
Lacarnit 330 mg Tablet is a medicine that contains Levocarnitine. It is used to treat severe carnitine deficiency. Carnitine is a protein that is made in your brain, liver, and kidneys. It helps the body in the conversion of fat into energy. This medicine is also used for the treatment of secondary carnitine deficiency (when there is not enough carnitine in the blood). Lacarnit 330 mg Tablet works by increasing the levels of carnitine in the body. Lacarnit 330 mg Tablet may cause side effects like nausea, vomiting, headache, etc. Seek medical attention if these side effects persist for a longer period. Avoid taking Lacarnit 330 mg Tablet if you are allergic to it. Lacarnit 330 mg Tablet should be taken with food to avoid stomach discomfort. The dose and duration of the treatment will be decided by your doctor based on your condition. Do not take more than the prescribed dose. In case of overdose, consult your doctor at the earliest. Use Lacarnit 330 mg Tablet with caution if you have diabetes because it can alter your blood glucose levels.

Substitutes

List of substitutes for Lacarnit 330 mg Tablet

Nucarnit 330 mg Tablet
Emcure Pharmaceuticals Ltd.

Side effects

Major & minor side effects for Lacarnit 330 mg Tablet

  • Increased blood pressure
  • Increased heartbeat
  • Fever
  • Diarrhoea
  • Headache
  • Nausea or vomiting
  • Depression
  • Dizziness
  • Skin rash

Uses of Lacarnit 330 mg Tablet

What is it prescribed for?

  • Primary systemic carnitine deficiency
  • Secondary carnitine deficiency
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The onset of action of Lacarnit 330 mg Tablet is not known.
  • How long do the effects of this medicine last?
    The amount of time for which Lacarnit 330 mg Tablet remains active in the body is not known.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendency has been reported for Lacarnit 330 mg Tablet.
  • Can this medicine be taken during pregnancy?
    Lacarnit 330 mg Tablet is considered safe for use in pregnancy. However, discuss all the risks and benefits with your doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    Lacarnit 330 mg Tablet is safe to be used during breastfeeding. This medicine is known to pass into breast milk and does not cause harm to your infant. However, inform your doctor if you are breastfeeding before taking this medicine.

Allergy

Avoid taking Lacarnit 330 mg Tablet if you are allergic to it. Seek immediate medical attention if you notice any symptoms such as skin rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, breathing difficulty, etc.
Warnings for special population

Pregnancy

Lacarnit 330 mg Tablet is considered safe for use in pregnancy. However, discuss all the risks and benefits with your doctor before taking this medicine.

Breast-feeding

Lacarnit 330 mg Tablet is safe to be used during breastfeeding. This medicine is known to pass into breast milk and does not cause harm to your infant. However, inform your doctor if you are breastfeeding before taking this medicine.
General warnings

Kidney diseases

Lacarnit 330 mg Tablet is excreted from the kidneys. If you have kidney problems this medicine may accumulate in your kidneys and leads to serious side effects. Your doctor may adjust the dose of this medicine based on your clinical condition. Lacarnit 330 mg Tablet is not recommended for use if you have severe kidney problems.

Stomach discomfort

Lacarnit 330 mg Tablet may cause stomach irritation leading to side effects such as nausea, vomiting, stomach pain or cramps. Seek medical help if you notice any of these symptoms.

Other medicines

Lacarnit 330 mg Tablet may interact with many other medicines and may cause severe side effects. Hence, inform the doctor about all your concurrent medicines including any herbs and supplements before beginning treatment with Lacarnit 330 mg Tablet.

Missed Dose

Do not skip any dose of Lacarnit 330 mg Tablet. If you forget to take a dose of this medicine, take it as soon as you remember. If it is time for your next dose, skip the missed dose. Do not double the dose to compensate for a missed one.

Overdose

Never take more than the prescribed dose. Contact your doctor in case of an overdose with Lacarnit 330 mg Tablet for further guidance.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Dicumarol

Warfarin

Disease interactions

Diabetes Mellitus

Lacarnit 330 mg Tablet may interfere with the insulin secretion in the body and may increase the risk of high blood sugar levels in your body. Consult your doctor if you experience unusual weakness, frequent urination, or any diabetes-associated side effects after taking this medicine.
Food interactions
Information not available.
Lab interactions
Information not available.
Lacarnit 330 mg Tablet is used for treating carnitine deficiency. It can be taken with or without food as instructed by your doctor. Do not take this medicine in more doses than prescribed. Consult your doctor if you experience any undesirable effects. Ensure that the treatment is completed. Do not stop taking Lacarnit 330 mg Tablet without consulting your doctor. Let your doctor know of all your current medicines as well as your medical conditions before taking Lacarnit 330 mg Tablet. Foods containing vitamin C like orange, lemon, kiwi, etc., can increase the carnitine levels in your body. Taking Lacarnit 330 mg Tablet along with dairy products may show a faster action. Keep away from the reach of children and pets. Ensure that the unused medicine is disposed of properly.
Miscelleneous

To be taken immediately after food

To be taken as instructed by doctor

Does not cause sleepiness

How it works
Lacarnit 330 mg Tablet works by improving the low levels of carnitine in the body. It helps the body produce energy and improves the efficiency of body function.
Legal Status

Approved

Approved

Approved

Unknown

Classification

Category

Quaternary ammonium derivatives, Oral nutritional supplements

Schedule

Schedule H

Pdf.hres.ca. 2021. [online] Available at: < [Accessed 15 June 2021].

https://pdf.hres.ca/dpd_pm/00041980.PDF>

Accessdata.fda.gov. 2021. [online] Available at: < [Accessed 15 June 2021].

https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/018948s024,019257s011lbl.pdf>

Medicines.org.uk. 2021. Levocarnitine 30% Paediatric Oral Solution - Summary of Product Characteristics (SmPC) - (emc). [online] Available at: < [Accessed 15 June 2021].

https://www.medicines.org.uk/emc/product/5140/smpc>
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 14 Oct 2021

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.